Affiliation:
1. Department of Pharmaceutical Sciences, Pharmacological and Diagnostic Research Center, Faculty of Pharmacy Al‐Ahliyya Amman University Amman Jordan
2. Al‐Kitab University Kirkuk Iraq
3. Department of Pharmaceutical Chemistry, Faculty of Pharmacy Mutah University Al‐Karak Jordan
4. Biology Department College of Science, Mutah University Al‐Karak Jordan
5. Department of Pharmaceutics and Pharmaceutical Technology, Pharmacological and Diagnostics Research Centre, Faculty of Pharmacy Al‐Ahliyya Amman University Amman Jordan
6. Department of Cosmetic Science, Faculty of Allied Medical Sciences Al‐Ahliyya Amman University Amman Jordan
Abstract
AbstractBackgroundThe investigations of snail slime and its possible biological activities have been performed recently.AimThis study aimed to evaluate the properties of Helix aspersa snail slime (HAS), and carotenoids‐fortified slime (HASC).MethodsSnails were fed with carrots for 10 days. Slime was collected and extracted using water. Saponins identification, antioxidant, collagenase, and tyrosinase enzyme inhibition activities, carotenoids, total phenols, and flavonoids content, were determined. UHPLC–MS/MS analysis was performed for phytochemical characterization.ResultsSaponins were detected in the HAS extract only. However, HASC was shown to contain a higher carotenoid content than HAS (29.51 ± 0.4 vs. 18.11 ± 0.2 μg/g). similarly, total phenolic and flavonoid content were higher for the the HASC extract compared to the HAS (182.3 ± 5.2 vs. 150.28 ± 3.3 mg/g equivalent to gallic acid), and (77.62 ± 1.2 vs. 14.19 ± 0.9 mg/g equivalent to quercetin). As expected, the HASC extract exhibited higher antioxidant activity compared to the HAS, using DPPH and the ABTS assays (IC50 = 7.75 ± 0.14 vs. 20.1 ± 0.4 μg/mL), and (IC50 = 7.6 ± 0.26 vs. 19.57 ± 1.4 μg/mL). UHPLC–MS/MS analysis revealed the presence of several phytocomponents of which, hexadecanoic acid and ascorbic acid, were observed in the HASC extract. Furthermore, HASC extract exhibited superior inhibitory activity compared to HAS against collagenase and tyrosinase enzymes (IC50 = 8.4 ± 1.19 vs. 15.3 ± 1.12 μg/mL) and (IC50 = 30.1 ± 0.91 vs. 35 ± 1.3 μg/mL).ConclusionThese findings highlight the potential of HASC as a valuable ingredient in various pharmaceutical applications, due to their content of various phenolic, antioxidants, carotenoids, hexadecanoic, and ascorbic acids. The latter is well known for its great cosmeceutical applications used for slowing the process of skin aging.